Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension

Biomark Med. 2021 Aug;15(12):1021-1034. doi: 10.2217/bmm-2021-0009. Epub 2021 Jul 22.

Abstract

Aim: This study assessed the utility of osteopontin (OPN) and galectin-3 (Gal-3) as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertension (PH). Materials & methods: We examined plasma levels of OPN and Gal-3 in patients with PH (n = 62), dilated cardiomyopathy (n = 34), left ventricular hypertrophy (LVH; n = 47), and controls without right ventricle (RV) or LV abnormalities (n = 38). Results: OPN and Gal-3 levels were higher in PH, dilated cardiomyopathy and LVH than in the controls. OPN concentrations in PH patients with maladaptive RV were significantly higher than in those with adaptive RV. Gal-3 did not differentiate between adaptive and maladaptive RV remodeling in PH. OPN and Gal-3 levels did not correlate with parameters of LV remodeling. Conclusion: OPN is a potential biomarker of RV maladaptation.

Keywords: CTEPH; DCM; IPAH; LV-hypertrophy; RV-PA coupling; fibrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood*
  • Female
  • Galectin 3 / blood*
  • Humans
  • Hypertension, Pulmonary / blood*
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / physiopathology
  • Hypertrophy, Left Ventricular / blood
  • Hypertrophy, Left Ventricular / diagnosis
  • Hypertrophy, Left Ventricular / physiopathology
  • Male
  • Middle Aged
  • Osteopontin / blood*
  • Sensitivity and Specificity
  • Ventricular Dysfunction, Right / blood
  • Ventricular Dysfunction, Right / diagnosis
  • Ventricular Dysfunction, Right / physiopathology
  • Ventricular Remodeling / physiology*

Substances

  • Biomarkers
  • Galectin 3
  • Osteopontin